Leukotriene B4, an endogenous stimulator of the innate immune response against pathogens.

J Innate Immun

Laboratory of Innate Immunology, Centre Hospitalier Universitaire de Québec, and Department of Molecular Medicine, Laval University, Quebec City, Que., Canada.

Published: November 2015

Leukotriene B4 (LTB4) is an endogenous lipid mediator of inflammation derived from arachidonic acid by the sequential action of cytosolic phospholipase A2 and 5-lipoxygenase. This mediator was initially recognized for its involvement in the recruitment of neutrophils. However, in the last decade, LTB4 has been clearly demonstrated to play a significant role in the control of microbial infections through its ability to activate host innate defenses. In this review, we will focus on the modulator effects of LTB4 on the innate defenses and discuss its therapeutic potential against viral pathogens.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741447PMC
http://dx.doi.org/10.1159/000353694DOI Listing

Publication Analysis

Top Keywords

innate defenses
8
leukotriene endogenous
4
endogenous stimulator
4
stimulator innate
4
innate immune
4
immune response
4
response pathogens
4
pathogens leukotriene
4
leukotriene ltb4
4
ltb4 endogenous
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!